March 2009 PMID 19228612

Percutaneous coronary intervention versus coronary-artery bypass grafting for severe coronary artery disease.

Patrick W Serruys, Marie-Claude Morice, A Pieter Kappetein, Antonio Colombo, David R Holmes, Michael J Mack, Elisabeth Ståhle, Ted E Feldman, Marcel van den Brand, Eric J Bass, Nic Van Dyck, Katrin Leadley, Keith D Dawkins, Friedrich W Mohr

Download social card

Mentions

21
Peak: 1 in Mar 2022
across 5 sources since Mar 2022

Extended reach

10,278
potential audience

Total likes

15

Video views

752

Mentions per month

Mar 2022 – Jun 2025

Where it's discussed

  • News8 articles
  • X / Twitter5 posts
  • Blogs4 articles
  • Bluesky2 posts
  • YouTube2 videos

AI synopsis

What people are saying

The discussions demonstrate a balanced interest, as some users compare the article to earlier trials such as FAME 3, and others emphasize the importance of evidence-based practices in cardiology, using tone and references that suggest a meaningful exchange of ideas and respect for scientific debate.

AgreementModerate agreement

Most discussions acknowledge the study's findings, emphasizing the continued relevance of CABG over PCI for severe coronary cases, though some express curiosity about the evolving evidence.

InterestModerate interest

The discussions show a moderate level of interest, with some participants referencing related trials and the importance of evidence-based medicine, indicating engagement but not overwhelming curiosity.

EngagementModerate engagement

Posts include references to specific studies like FAME 3 and solicit opinions from professionals, showing active engagement and critique rather than superficial comments.

ImpactModerate impact

The discussions highlight ongoing debates and reflections on clinical decision-making, suggesting that the article influences medical practice and scholarly conversations.

Abstract in brief

  • This trial compared two treatments, PCI and CABG, for severe coronary artery disease, finding that PCI had higher rates of adverse events mainly due to more repeat procedures, leading to the conclusion that CABG remains the preferred standard for such cases.
  • Both treatments showed similar rates of death and heart attacks after 12 months, but stroke was more common in patients who received CABG.
  • Since the primary goal of the study was to show PCI was not worse than CABG, and it was found to be less effective in preventing repeat revascularization, CABG is still considered the best option for three-vessel or left main coronary artery disease.]

Top posts

Most liked on X and Bluesky
TSMA
@ThoracicStudent · X

And that’s it for this week! Thank you for joining us. Be sure to check out the full #SYNTAX paper at https://t.co/y1U4aAMNOF and an amazing summary available at https://t.co/c02syUV3Bc. See you next week for #ThoracicThursday !

Oct 5, 2023 · 8 likes · 5,005 followers View post →
Raad Chowdhury, MD, FASN
@rc_oncneph · X

@GarySingerMD @CardioNerds Not a cardio nerd, I remember during medicine training this was big, still applicable? https://t.co/VBQIH3ZCoq

Nov 28, 2022 · 3 likes · 1,443 followers View post →
Boris Sobolev
@soboleffspaces · X

@ADAlthousePhD @yudapearl @f2harrell @stephensenn @SMuellerLab I'm sorry to break it to you, but your ideation is wrong. In the spirit of the trialists' advice to causal theorists, please take the time to read how it was actually done, https://t.co/cNpxoqLohc https://t.co/ps1a0oGnvU then come back for an informed conversation.

Mar 3, 2022 · 1,443 followers View post →
Landmark Trials
@LandmarkTrials · X

Original article: https://t.co/Qv77XSCIb0

Dec 31, 2022 · 847 followers View post →
Dr Cailbhe Doherty
@DohertyCailbhe · X

https://t.co/89qO7Ds6TL This lecture discusses the steps of evidence-based medicine #physiotherapy #physiotalk #evidence

Sep 13, 2022 · 787 followers View post →
BaladoCritique : club de lecture médical
@baladocritique.bsky.social · Bluesky

"Outcomes after fractional flow reserve-guided percutaneous coronary intervention versus coronary artery bypass grafting (FAME 3): 5-year follow-up of a multicentre, open-label, randomised trial." Publié ce jour dans @thelancet.bsky.social #MedSky #CardioSky www.thelancet.com/journals/lan...

Apr 26, 2025 View post →

All mentions

Nixa Sedes, MD
@nixassedes.bsky.social · Bluesky

Percutaneous Coronary Intervention Versus Coronary Artery Bypass Grafting in Patients With 3‐Vessel Coronary Artery Disease and Diabetes

Jun 18, 2025 · 1 share View post →
BaladoCritique : club de lecture médical
@baladocritique.bsky.social · Bluesky

"Outcomes after fractional flow reserve-guided percutaneous coronary intervention versus coronary artery bypass grafting (FAME 3): 5-year follow-up of a multicentre, open-label, randomised trial." Publié ce jour dans @thelancet.bsky.social #MedSky #CardioSky www.thelancet.com/journals/lan...

Apr 26, 2025 View post →
TSMA
@ThoracicStudent · X

And that’s it for this week! Thank you for joining us. Be sure to check out the full #SYNTAX paper at https://t.co/y1U4aAMNOF and an amazing summary available at https://t.co/c02syUV3Bc. See you next week for #ThoracicThursday !

Oct 5, 2023 · 8 likes · 5,005 followers View post →
Landmark Trials
@LandmarkTrials · X

Original article: https://t.co/Qv77XSCIb0

Dec 31, 2022 · 847 followers View post →
Raad Chowdhury, MD, FASN
@rc_oncneph · X

@GarySingerMD @CardioNerds Not a cardio nerd, I remember during medicine training this was big, still applicable? https://t.co/VBQIH3ZCoq

Nov 28, 2022 · 3 likes · 1,443 followers View post →
Dr Cailbhe Doherty
@DohertyCailbhe · X

https://t.co/89qO7Ds6TL This lecture discusses the steps of evidence-based medicine #physiotherapy #physiotalk #evidence

Sep 13, 2022 · 787 followers View post →
Boris Sobolev
@soboleffspaces · X

@ADAlthousePhD @yudapearl @f2harrell @stephensenn @SMuellerLab I'm sorry to break it to you, but your ideation is wrong. In the spirit of the trialists' advice to causal theorists, please take the time to read how it was actually done, https://t.co/cNpxoqLohc https://t.co/ps1a0oGnvU then come back for an informed conversation.

Mar 3, 2022 · 1,443 followers View post →